Literature DB >> 15034766

Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease.

Katrina A B Goddard1, Jane M Olson, Haydeh Payami, Monique van der Voet, Helena Kuivaniemi, Gerard Tromp.   

Abstract

Recently, we reported evidence of linkage on chromosome 20 for Alzheimer disease (AD) using a novel statistical approach to incorporate covariates (e.g., age, ApoE genotype) into the analysis. These results suggest that very elderly subjects (>85 years), and individuals who carry an epsilon2 allele at the ApoE locus are more likely to be linked to this candidate region. The region on chromosome 20 includes a strong candidate gene, cystatin C (CST3), which has previously been associated with AD in case-control studies. We investigated these findings further by genotyping additional markers to narrow the candidate region, and to identify evidence of linkage disequilibrium as additional support for a susceptibility locus on chromosome 20. We selected 43 elderly sibships (89 subjects) from the NIMH AD Genetics Initiative based on current age older than 84 years, and identified 129 unrelated control subjects who were older than 84 years from the Oregon Brain Aging Study to conduct linkage and association studies in this region. Fourteen additional markers were evaluated, including 4 markers located within or near CST3. We narrowed the candidate region on chromosome 20 to an 11.8-cM region between markers D20S174 and D20S471, which includes the CST3 candidate gene. In addition, we observed evidence of association for markers located near the CST3 candidate gene, with P values between 0.002 and 0.08 for two-locus haplotypes. These results support the presence of a susceptibility locus for AD in the vicinity of CST3 for very elderly subjects with AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034766     DOI: 10.1007/s10048-004-0174-3

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  47 in total

Review 1.  Candidate-gene approaches for studying complex genetic traits: practical considerations.

Authors:  Holly K Tabor; Neil J Risch; Richard M Myers
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

2.  A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.

Authors:  R C Dodel; Y Du; C Depboylu; A Kurz; B Eastwood; M Farlow; W H Oertel; U Müller; M Riemenschneider
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

3.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  Alzheimer's disease and the cystatin C gene polymorphism: an association study.

Authors:  K Beyer; J I Lao; M Gómez; N Riutort; P Latorre; J L Mate; A Ariza
Journal:  Neurosci Lett       Date:  2001-11-23       Impact factor: 3.046

5.  Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C.

Authors:  M Abrahamson; A Grubb; I Olafsson; A Lundwall
Journal:  FEBS Lett       Date:  1987-06-01       Impact factor: 4.124

6.  Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.

Authors:  M Strittmatter; H Cramer; C Reuner; D Strubel; G Hamann; K Schimrigk
Journal:  Biol Psychiatry       Date:  1997-06-01       Impact factor: 13.382

7.  Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation.

Authors:  D B Howieson; L A Holm; J A Kaye; B S Oken; J Howieson
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

8.  Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm.

Authors:  M Slatkin; L Excoffier
Journal:  Heredity (Edinb)       Date:  1996-04       Impact factor: 3.821

9.  Somatostatin cerebrospinal fluid levels in dementia.

Authors:  A Molins; R Catalán; J Sahuquillo; J M Castellanos; A Codina; R Galard
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

10.  Comprehensive human genetic maps: individual and sex-specific variation in recombination.

Authors:  K W Broman; J C Murray; V C Sheffield; R L White; J L Weber
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

View more
  11 in total

1.  Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.

Authors:  Joseph H Lee; Sandra Barral; Rong Cheng; Inara Chacon; Vincent Santana; Jennifer Williamson; Rafael Lantigua; Martin Medrano; Ivonne Z Jimenez-Velazquez; Yaakov Stern; Benjamin Tycko; Ekaterina Rogaeva; Yosuke Wakutani; Toshitaka Kawarai; Peter St George-Hyslop; Richard Mayeux
Journal:  Neurogenetics       Date:  2007-10-17       Impact factor: 2.660

2.  Phactr2 and Parkinson's disease.

Authors:  Christian Wider; Sarah J Lincoln; Michael G Heckman; Nancy N Diehl; Jeremy T Stone; Kristoffer Haugarvoll; Jan O Aasly; J Mark Gibson; Timothy Lynch; Alex Rajput; Michele L Rajput; Ryan J Uitti; Zbigniew K Wszolek; Matthew J Farrer; Owen A Ross
Journal:  Neurosci Lett       Date:  2009-02-10       Impact factor: 3.046

3.  Exceptional brain aging in a rural population-based cohort.

Authors:  Jeffrey Kaye; Yvonne Michael; James Calvert; Marjorie Leahy; Debbie Crawford; Patricia Kramer
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

4.  A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population.

Authors:  Fan Liu; Alejandro Arias-Vásquez; Kristel Sleegers; Yurii S Aulchenko; Manfred Kayser; Pascual Sanchez-Juan; Bing-Jian Feng; Aida M Bertoli-Avella; John van Swieten; Tatiana I Axenovich; Peter Heutink; Christine van Broeckhoven; Ben A Oostra; Cornelia M van Duijn
Journal:  Am J Hum Genet       Date:  2007-05-29       Impact factor: 11.025

Review 5.  APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

Authors:  Susan Bookheimer; Alison Burggren
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

Review 6.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

Review 7.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

8.  Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways.

Authors:  Paolo Olgiati; Antonis M Politis; George N Papadimitriou; Diana De Ronchi; Alessandro Serretti
Journal:  Int J Alzheimers Dis       Date:  2011-12-10

9.  Cystatin C in Alzheimer's disease.

Authors:  Gurjinder Kaur; Efrat Levy
Journal:  Front Mol Neurosci       Date:  2012-07-06       Impact factor: 5.639

10.  Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.

Authors:  Sander W van der Laan; Tove Fall; Aicha Soumaré; Alexander Teumer; Sanaz Sedaghat; Jens Baumert; Delilah Zabaneh; Jessica van Setten; Ivana Isgum; Tessel E Galesloot; Johannes Arpegård; Philippe Amouyel; Stella Trompet; Melanie Waldenberger; Marcus Dörr; Patrik K Magnusson; Vilmantas Giedraitis; Anders Larsson; Andrew P Morris; Janine F Felix; Alanna C Morrison; Nora Franceschini; Joshua C Bis; Maryam Kavousi; Christopher O'Donnell; Fotios Drenos; Vinicius Tragante; Patricia B Munroe; Rainer Malik; Martin Dichgans; Bradford B Worrall; Jeanette Erdmann; Christopher P Nelson; Nilesh J Samani; Heribert Schunkert; Jonathan Marchini; Riyaz S Patel; Aroon D Hingorani; Lars Lind; Nancy L Pedersen; Jacqueline de Graaf; Lambertus A L M Kiemeney; Sebastian E Baumeister; Oscar H Franco; Albert Hofman; André G Uitterlinden; Wolfgang Koenig; Christa Meisinger; Annette Peters; Barbara Thorand; J Wouter Jukema; Bjørn Odvar Eriksen; Ingrid Toft; Tom Wilsgaard; N Charlotte Onland-Moret; Yvonne T van der Schouw; Stéphanie Debette; Meena Kumari; Per Svensson; Pim van der Harst; Mika Kivimaki; Brendan J Keating; Naveed Sattar; Abbas Dehghan; Alex P Reiner; Erik Ingelsson; Hester M den Ruijter; Paul I W de Bakker; Gerard Pasterkamp; Johan Ärnlöv; Michael V Holmes; Folkert W Asselbergs
Journal:  J Am Coll Cardiol       Date:  2016-08-30       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.